| Difluocortolone | hsa00030 | Pentose phosphate pathway | 8.97E-03 | 1 | P11413 | G6PD | More | |
| Difluocortolone | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | |
| Difluocortolone | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | |
| Difluocortolone | hsa00480 | Glutathione metabolism | 1.35E-02 | 1 | P11413 | G6PD | More | |
| Difluocortolone | hsa00500 | Starch and sucrose metabolism | 2.00E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | |
| Difluocortolone | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | |
| Difluocortolone | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | |
| Difluocortolone | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | |
| Difluocortolone | hsa00730 | Thiamine metabolism | 5.29E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | |
| Difluocortolone | hsa00970 | Aminoacyl-tRNA biosynthesis | 1.21E-02 | 1 | P14868 | DARS | More | |
| Difluocortolone | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
| Difluocortolone | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | |
| Difluocortolone | hsa00983 | Drug metabolism - other enzymes | 2.44E-02 | 2 | P32320, P05164 | CDA, MPO | More | |
| Difluocortolone | hsa01200 | Carbon metabolism | 2.91E-02 | 1 | P11413 | G6PD | More | |
| Difluocortolone | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | |
| Difluocortolone | hsa03013 | RNA transport | 3.11E-02 | 2 | P68104, Q14232 | EEF1A1, EIF2B1 | More | |
| Difluocortolone | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 2.00E-02 | 7 | P09341, P25024, P25025, P47992, Q9UBD3, Q13651, P01375 | CXCL1, CXCR1, CXCR2, XCL1, XCL2, IL10RA, TNF | More | |
| Difluocortolone | hsa04064 | NF-kappa B signaling pathway | 4.58E-03 | 4 | Q13489, Q13546, Q9UDY8, Q9UNE0 | BIRC3, RIPK1, MALT1, EDAR | More | |
| Difluocortolone | hsa04071 | Sphingolipid signaling pathway | 1.94E-02 | 3 | Q9H228, P01375, Q9UQC2 | EDG8, TNF, GAB2 | More | |
| Difluocortolone | hsa04140 | Autophagy - animal | 3.61E-02 | 5 | Q9NQL2, P22694, Q14643, Q9H1Y0, Q04759 | RRAGD, PRKACB, ITPR1, ATG5, PRKCQ | More | |
| Difluocortolone | hsa04141 | Protein processing in endoplasmic reticulum | 3.89E-02 | 2 | P17861, Q9NR31 | XBP1, SAR1A | More | |
| Difluocortolone | hsa04210 | Apoptosis | 3.58E-02 | 4 | O76075, P01375, Q9NR28, Q16548 | DFFB, TNF, DIABLO, BCL2A1 | More | |
| Difluocortolone | hsa04211 | Longevity regulating pathway | 1.18E-02 | 3 | Q12778, Q9UEF7, Q96KQ7 | FOXO1, KL, EHMT2 | More | |
| Difluocortolone | hsa04213 | Longevity regulating pathway - multiple species | 2.85E-02 | 2 | Q9Y4H2, Q13547 | IRS2, HDAC1 | More | |
| Difluocortolone | hsa04217 | Necroptosis | 2.93E-02 | 3 | P01568, Q13489, Q13546 | IFNA21, BIRC3, RIPK1 | More | |
| Difluocortolone | hsa04340 | Hedgehog signaling pathway | 3.32E-02 | 2 | P49841, P22694 | GSK3B, PRKACB | More | |
| Difluocortolone | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | |
| Difluocortolone | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | |
| Difluocortolone | hsa04612 | Antigen processing and presentation | 3.60E-03 | 8 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | |
| Difluocortolone | hsa04613 | Neutrophil extracellular trap formation | 4.90E-05 | 18 | P11215, O60603, P05164, P08246, Q9UM07, Q13547, Q93077, P58876, P62807, Q16778, O60814, P68431, P20160, P08311, O75015, P21730, O43315, Q16539 | ITGAM, TLR2, MPO, ELA2, PADI4, HDAC1, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, AZU1, CTSG, FCGR3B, C5AR1, AQP9, MAPK14 | More | |
| Difluocortolone | hsa04620 | Toll-like receptor signaling pathway | 4.16E-02 | 2 | Q13546, P01568 | RIPK1, IFNA21 | More | |
| Difluocortolone | hsa04621 | NOD-like receptor signaling pathway | 3.13E-04 | 17 | Q16539, Q14643, P01568, Q13489, P10599, Q9H1Y0, P43490, O00463, Q13546, P29728, Q05823, P01375, P09341, P49913, P59665, P59666, P12838 | MAPK14, ITPR1, IFNA21, BIRC3, TXN, ATG5, PBEF1, TRAF5, RIPK1, OAS2, RNASEL, TNF, CXCL1, CAMP, DEFA1; DEFA1B, DEFA3, DEFA4 | More | |
| Difluocortolone | hsa04622 | RIG-I-like receptor signaling pathway | 2.39E-02 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | |
| Difluocortolone | hsa04623 | Cytosolic DNA-sensing pathway | 2.20E-03 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | |
| Difluocortolone | hsa04640 | Hematopoietic cell lineage | 1.10E-02 | 9 | P13612, P14778, P27930, P15144, P25063, P09693, P01732, P13765, P01375 | ITGA4, IL1R1, IL1R2, ANPEP, CD24, CD3G, CD8A, HLA-DOB, TNF | More | |
| Difluocortolone | hsa04650 | Natural killer cell mediated cytotoxicity | 3.11E-04 | 9 | P01375, P06239, O60880, P20963, Q13241, P26718, O75015, P26717, P26715 | TNF, LCK, SH2D1A, CD247, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1 | More | |
| Difluocortolone | hsa04657 | IL-17 signaling pathway | 1.80E-03 | 7 | O00463, Q16539, P49841, P09341, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF | More | |
| Difluocortolone | hsa04658 | Th1 and Th2 cell differentiation | 5.94E-04 | 9 | Q04759, P20963, P09693, Q16539, P06239, Q14765, P23771, Q9UL17, P13765 | PRKCQ, CD247, CD3G, MAPK14, LCK, STAT4, GATA3, TBX21, HLA-DOB | More | |
| Difluocortolone | hsa04659 | Th17 cell differentiation | 3.91E-03 | 9 | Q04759, Q16539, P06239, P13765, P14778, Q9UL17, P23771, P09693, P20963 | PRKCQ, MAPK14, LCK, HLA-DOB, IL1R1, TBX21, GATA3, CD3G, CD247 | More | |
| Difluocortolone | hsa04660 | T cell receptor signaling pathway | 6.95E-04 | 11 | P01375, Q04759, O95267, Q08881, P20963, P09693, P01732, Q13191, P06239, Q16539, P49841 | TNF, PRKCQ, RASGRP1, ITK, CD247, CD3G, CD8A, CBLB, LCK, MAPK14, GSK3B | More | |
| Difluocortolone | hsa04750 | Inflammatory mediator regulation of TRP channels | 3.61E-02 | 5 | P14778, P22694, Q16539, Q14643, Q04759 | IL1R1, PRKACB, MAPK14, ITPR1, PRKCQ | More | |
| Difluocortolone | hsa04910 | Insulin signaling pathway | 2.35E-02 | 3 | P22694, P06737, P49841 | PRKACB, PYGL, GSK3B | More | |
| Difluocortolone | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | |
| Difluocortolone | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | |
| Difluocortolone | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | |
| Difluocortolone | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | |
| Difluocortolone | hsa04975 | Fat digestion and absorption | 2.80E-02 | 1 | O14494 | PLPP1 | More | |
| Difluocortolone | hsa04976 | Bile secretion | 2.44E-02 | 2 | P22694, P08183 | PRKACB, ABCB1 | More | |
| Difluocortolone | hsa05010 | Alzheimer disease | 1.01E-02 | 3 | Q06055, P17861, P62195 | ATP5G2, XBP1, PSMC5 | More | |
| Difluocortolone | hsa05012 | Parkinson disease | 5.41E-03 | 3 | Q06055, P17861, P62195 | ATP5G2, XBP1, PSMC5 | More | |
| Difluocortolone | hsa05014 | Amyotrophic lateral sclerosis | 1.01E-02 | 3 | Q06055, P17861, P62195 | ATP5G2, XBP1, PSMC5 | More | |
| Difluocortolone | hsa05017 | Spinocerebellar ataxia | 1.42E-02 | 2 | P17861, P62195 | XBP1, PSMC5 | More | |
| Difluocortolone | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.66E-02 | 3 | Q06055, P17861, P62195 | ATP5G2, XBP1, PSMC5 | More | |
| Difluocortolone | hsa05034 | Alcoholism | 2.05E-05 | 7 | Q13547, Q93077, P58876, P62807, Q16778, O60814, P68431 | HDAC1, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
| Difluocortolone | hsa05132 | Salmonella infection | 9.85E-03 | 4 | Q13546, Q13489, O60282, P68371 | RIPK1, BIRC3, KIF5C, TUBB2C | More | |
| Difluocortolone | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | |
| Difluocortolone | hsa05134 | Legionellosis | 5.53E-03 | 2 | Q9NR31, P68104 | SAR1A, EEF1A1 | More | |
| Difluocortolone | hsa05135 | Yersinia infection | 3.72E-02 | 6 | P13612, P06239, Q16539, P01375, P49841, P01732 | ITGA4, LCK, MAPK14, TNF, GSK3B, CD8A | More | |
| Difluocortolone | hsa05140 | Leishmaniasis | 2.69E-02 | 6 | P13612, O75015, P13765, O60603, P01375, Q16539 | ITGA4, FCGR3B, HLA-DOB, TLR2, TNF, MAPK14 | More | |
| Difluocortolone | hsa05143 | African trypanosomiasis | 1.31E-02 | 2 | P69905, P68871 | HBA2, HBB | More | |
| Difluocortolone | hsa05144 | Malaria | 9.96E-05 | 7 | P60033, P69905, P68871, O60603, P01375, P35443, P26718 | CD81, HBA2, HBB, TLR2, TNF, THBS4, KLRK1 | More | |
| Difluocortolone | hsa05146 | Amoebiasis | 5.94E-04 | 9 | P09341, P14778, P27930, P01375, O60603, P05089, P22694, P12814, P08311 | CXCL1, IL1R1, IL1R2, TNF, TLR2, ARG1, PRKACB, ACTN1, CTSG | More | |
| Difluocortolone | hsa05150 | Staphylococcus aureus infection | 1.02E-03 | 7 | P21730, P21462, O75015, P59665, P59666, P12838, P49913 | C5AR1, FPR1, FCGR3B, DEFA1; DEFA1B, DEFA3, DEFA4, CAMP | More | |
| Difluocortolone | hsa05163 | Human cytomegalovirus infection | 2.51E-02 | 9 | P01375, Q14643, P22694, P49841, P14778, Q13651, P25025, Q16539, O00463 | TNF, ITPR1, PRKACB, GSK3B, IL1R1, IL10RA, CXCR2, MAPK14, TRAF5 | More | |
| Difluocortolone | hsa05202 | Transcriptional misregulation in cancer | 4.29E-03 | 13 | P14780, P27930, Q15744, Q16548, P11215, P05164, P12838, P08246, Q9C0K0, P41182, Q13547, P12980, P24522 | MMP9, IL1R2, CEBPE, BCL2A1, ITGAM, MPO, DEFA4, ELA2, BCL11B, BCL6, HDAC1, LYL1, GADD45A | More | |
| Difluocortolone | hsa05203 | Viral carcinogenesis | 1.22E-03 | 6 | Q13547, Q15283, P58876, P62807, Q16778, O60814 | HDAC1, RASA2, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12 | More | |
| Difluocortolone | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
| Difluocortolone | hsa05230 | Central carbon metabolism in cancer | 1.12E-02 | 1 | P11413 | G6PD | More | |
| Difluocortolone | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.42E-02 | 7 | O95267, P20963, P09693, P06239, O60603, Q04759, Q16539 | RASGRP1, CD247, CD3G, LCK, TLR2, PRKCQ, MAPK14 | More | |
| Difluocortolone | hsa05310 | Asthma | 1.62E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | |
| Difluocortolone | hsa05321 | Inflammatory bowel disease | 1.09E-03 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | |
| Difluocortolone | hsa05322 | Systemic lupus erythematosus | 4.80E-06 | 7 | P09871, Q93077, P58876, P62807, Q16778, O60814, P68431 | C1S, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
| Difluocortolone | hsa05332 | Graft-versus-host disease | 1.76E-02 | 4 | P13765, P01375, P26715, Q13241 | HLA-DOB, TNF, KLRC1, KLRD1 | More | |
| Difluocortolone | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | |
| Difluocortolone | hsa05415 | Diabetic cardiomyopathy | 3.59E-02 | 1 | P11413 | G6PD | More | |
